Cargando…
Advances in the treatment of locally advanced rectal cancer
Locally advanced rectal cancer requires multidisciplinary care. In the United States, most patients are treated with neoadjuvant chemoradiation delivered over 25‐28 days, total mesorectal excision, and 4 months of adjuvant chemotherapy. While effective, this trimodal approach is arduous. Alternative...
Autores principales: | Ali, Fadwa, Keshinro, Ajaratu, Weiser, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832958/ https://www.ncbi.nlm.nih.gov/pubmed/33532678 http://dx.doi.org/10.1002/ags3.12389 |
Ejemplares similares
-
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery
por: Weiser, Martin R., et al.
Publicado: (2021) -
Novelties in treatment of locally advanced rectal cancer
por: Grass, Fabian, et al.
Publicado: (2018) -
Strategies to Optimize Treatment for Locally Advanced Rectal Cancer
por: Hu, Xiaoyu, et al.
Publicado: (2022) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018) -
Selection Criteria for the Radical Treatment of Locally Advanced Rectal Cancer
por: Davies, Mansel Leigh, et al.
Publicado: (2011)